{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:38:39Z","timestamp":1790185119458,"version":"4.1.0"},"reference-count":177,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2022,11,20]],"date-time":"2022-11-20T00:00:00Z","timestamp":1668902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004166","name":"Medical University of Warsaw","doi-asserted-by":"publisher","award":["1MA\/N\/2022"],"award-info":[{"award-number":["1MA\/N\/2022"]}],"id":[{"id":"10.13039\/501100004166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union \u2014The European Regional Development Fund","award":["1MA\/N\/2022"],"award-info":[{"award-number":["1MA\/N\/2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The automatism of cardiac pacemaker cells, which is tuned, is regulated by the autonomic nervous system (ANS) and multiple endocrine and paracrine factors, including cardiovascular peptides. The cardiovascular peptides (CPs) form a group of essential paracrine factors affecting the function of the heart and vessels. They may also be produced in other organs and penetrate to the heart via systemic circulation. The present review draws attention to the role of vasopressin (AVP) and some other cardiovascular peptides (angiotensins, oxytocin, cytokines) in the regulation of the cardiovascular system in health and cardiovascular diseases, especially in post-infarct heart failure, hypertension and cerebrovascular strokes. Vasopressin is synthesized mostly by the neuroendocrine cells of the hypothalamus. There is also evidence that it may be produced in the heart and lungs. The secretion of AVP and other CPs is markedly influenced by changes in blood volume and pressure, as well as by other disturbances, frequently occurring in cardiovascular diseases (hypoxia, pain, stress, inflammation). Myocardial infarction, hypertension and cardiovascular shock are associated with an increased secretion of AVP and altered responsiveness of the cardiovascular system to its action. The majority of experimental studies show that the administration of vasopressin during ventricular fibrillation and cardiac arrest improves resuscitation, however, the clinical studies do not present consisting results. Vasopressin cooperates with the autonomic nervous system (ANS), angiotensins, oxytocin and cytokines in the regulation of the cardiovascular system and its interaction with these regulators is altered during heart failure and hypertension. It is likely that the differences in interactions of AVP with ANS and other CPs have a significant impact on the responsiveness of the cardiovascular system to vasopressin in specific cardiovascular disorders.<\/jats:p>","DOI":"10.3390\/ijms232214414","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T03:05:11Z","timestamp":1668999911000},"page":"14414","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Heart as a Target of Vasopressin and Other Cardiovascular Peptides in Health and Cardiovascular Diseases"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3761-508X","authenticated-orcid":false,"given":"Ewa","family":"Szczepanska-Sadowska","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Physiology, Laboratory of Center for Preclinical Research, The Medical University of Warsaw, Banacha 1B, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,20]]},"reference":[{"key":"ref_1","first-page":"R111","article-title":"Supramedullary inputs to cardiovascular neurons of rostral ventrolateral medulla in rats","volume":"265","author":"Agarwal","year":"1993","journal-title":"Am. J. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-201X.2003.01070.x","article-title":"Medullary and supramedullary mechanisms regulating sympathetic vasomotor tone","volume":"177","author":"Dampney","year":"2003","journal-title":"Acta Physiol. Scand."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.302549","article-title":"Role of the autonomic nervous system in modulating cardiac arrhythmias","volume":"114","author":"Shen","year":"2014","journal-title":"Circ. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1113\/JP282064","article-title":"Vagus nerve stimulation activates nucleus of solitary tract neurons via supramedullary pathways","volume":"599","author":"Cooper","year":"2021","journal-title":"J. Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2006.12.010","article-title":"Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice","volume":"559","author":"Hiroyama","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1038\/emm.2016.20","article-title":"Crosstalk between the heart and peripheral organs in heart failure","volume":"48","author":"Jahng","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0040-1710320","article-title":"Vasopressor therapy in the intensive care unit","volume":"42","author":"Russell","year":"2021","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_8","first-page":"509","article-title":"Brain and cardiovascular diseases: Common neurogenic background of cardiovascular, metabolic and inflammatory diseases","volume":"61","author":"Ufnal","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Szczepanska-Sadowska, E., Wsol, A., Cudnoch-Jedrzejewska, A., and \u017bera, T. (2021). Complementary role of oxytocin and vasopressin in cardiovascular regulation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111465"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11906-018-0823-9","article-title":"Dysregulation of the renin-angiotensin system and the vasopressinergic system interactions in cardiovascular disorders","volume":"20","author":"Czarzasta","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Nickel, C.H., Bingisser, R., and Morgenthaler, N.G. (2012). The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med., 10.","DOI":"10.1186\/1741-7015-10-7"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/eurheartj\/ehv320","article-title":"CardioPulse: \u2018Ten Commandments\u2019 of 2015 European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (NSTE-ACS)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0079-6123(08)64379-4","article-title":"Vasopressin and oxytocin: Distribution and putative functions in the brain","volume":"60","author":"Buijs","year":"1983","journal-title":"Prog. Brain Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e12998","DOI":"10.1111\/jne.12998","article-title":"Vasopressin: An output signal from the suprachiasmatic nucleus to prepare physiology and behaviour for the resting phase","volume":"33","author":"Buijs","year":"2021","journal-title":"J. Neuroendocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0304-3835(94)90007-8","article-title":"Vasopressin and vasopressin-receptor immunoreactivity in small-cell lung carcinoma (SCCL) cell lines: Disruption in the activation cascade of V1a-receptors in variant SCCL","volume":"82","author":"Fay","year":"1994","journal-title":"Cancer Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"H2262","DOI":"10.1152\/ajpheart.01320.2006","article-title":"Functional arginine vasopressin system in early heart maturation","volume":"293","author":"Gutkowska","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cne.1137","article-title":"Neuropeptide expression in rat paraventricular hypothalamic neurons that project to the spinal cord","volume":"433","author":"Hallbeck","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.RES.84.3.365","article-title":"Evidence for a vasopressin system in the rat heart","volume":"84","author":"Hupf","year":"1999","journal-title":"Circ. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.npep.2015.03.003","article-title":"The secretion patterns and roles of cardiac and circulating arginine vasopressin during the development of heart failure","volume":"51","author":"Chen","year":"2015","journal-title":"Neuropeptides"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1152\/physrev.00035.2011","article-title":"Vasopressin V1a and V1b receptors: From molecules to physiological systems","volume":"92","author":"Koshimizu","year":"2012","journal-title":"Physiol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2174\/1389200218666170119145900","article-title":"Vasopressin and related peptides; potential value in diagnosis, prognosis and treatment of clinical disorders","volume":"18","author":"Zera","year":"2017","journal-title":"Curr. Drug Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"F351","DOI":"10.1152\/ajprenal.00049.2006","article-title":"Axial heterogeneity of vasopressin-receptor subtypes along the human and mouse collecting duct","volume":"292","author":"Carmosino","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neulet.2011.05.049","article-title":"Down-regulation of V1a vasopressin receptors in the cerebellum after myocardial infarction","volume":"499","author":"Milik","year":"2011","journal-title":"Neurosci. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.npep.2014.07.004","article-title":"Altered expression of V1a receptors mRNA in the brain and kidney after myocardial infarction and chronic stress","volume":"48","author":"Milik","year":"2014","journal-title":"Neuropeptides"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1210\/endo.135.4.7925112","article-title":"Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature","volume":"135","author":"Ostrowski","year":"1994","journal-title":"Endocrinology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/endo.131.1.1535312","article-title":"Distribution of V1a and V2 vasopressin receptor messenger ribonucleic acids in rat liver, kidney, pituitary and brain","volume":"131","author":"Ostrowski","year":"1992","journal-title":"Endocrinology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yfrne.2017.10.004","article-title":"Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery","volume":"51","author":"Song","year":"2018","journal-title":"Front. Neuroendocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0361-9230(02)00943-7","article-title":"Differential expression of vasopressin V1a and V1b receptors mRNA in the brain of renin transgenic TGR(mRen2)27 and Sprague-Dawley rats","volume":"59","author":"Kumosa","year":"2003","journal-title":"Brain Res. Bull."},{"key":"ref_30","first-page":"349","article-title":"Vasopressin V1a, V1b and V2 receptors mRNA in the kidney and heart of the renin transgenic TGR(mRen2)27 and Sprague Dawley rats","volume":"53","author":"Luszczyk","year":"2002","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0922-4106(94)90226-7","article-title":"Distribution and developmental change of vasopressin V1A and V2 receptor mRNA in rats","volume":"267","author":"Hirasawa","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2826.1999.00332.x","article-title":"Localization of vasopressin (V1a) receptor binding and mRNA in the rhesus monkey brain","volume":"11","author":"Young","year":"1999","journal-title":"J. Neuroendocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.peptides.2018.03.004","article-title":"Vasopressin V1a receptors are present in the carotid body and contribute to the control of breathing in male Sprague-Dawley rats","volume":"102","author":"Przybylski","year":"2018","journal-title":"Peptides"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygcen.2017.10.011","article-title":"Neuroanatomical distribution and function of the vasopressin V1B receptor in the rat brain deciphered using specific fluorescent ligands","volume":"258","author":"Corbani","year":"2018","journal-title":"Gen. Comp. Endocrinol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"E566","DOI":"10.1152\/ajpendo.00148.2003","article-title":"Pancreatic vasopressin V1b receptors: Characterization in In-R1-G9 cells and localization in human pancreas","volume":"285","author":"Folny","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000108655","article-title":"Vasopressin receptor mRNA expression in the human gastrointestinal tract","volume":"40","author":"Monstein","year":"2008","journal-title":"Eur. Surg. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0167-0115(93)90182-8","article-title":"Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors","volume":"45","author":"Morel","year":"1993","journal-title":"Regul. Pept."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00005344-199004000-00009","article-title":"V2-like receptors mediate cerebral blood flow increase following vasopressin administration in rats","volume":"15","year":"1990","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/01.RES.58.5.631","article-title":"Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs","volume":"58","author":"Liard","year":"1986","journal-title":"Circ. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI1250","article-title":"Intracellular trafficking of factor VIII to von Willebrand factor storage granules","volume":"101","author":"Rosenberg","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_41","first-page":"H751","article-title":"Chronic intravenous administration of V1 arginine vasopressin agonist results in sustained hypertension","volume":"267","author":"Cowley","year":"1994","journal-title":"Am. J. Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/10253890701794445","article-title":"Differential sensitisation to central cardiovascular effects of angiotensin II in rats with a myocardial infarct: Relevance to stress and interaction with vasopressin","volume":"11","author":"Dobruch","year":"2008","journal-title":"Stress"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"R672","DOI":"10.1152\/ajpregu.00543.2009","article-title":"Brain vasopressin V(1) receptors contribute to enhanced cardiovascular responses to acute stress in chronically stressed rats and rats with myocardial infarction","volume":"298","author":"Dobruch","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.physbeh.2014.06.011","article-title":"The effect of blockade of the central V1 vasopressin receptors on anhedonia in chronically stressed infarcted and non-infarcted rats","volume":"135","author":"Puchalska","year":"2014","journal-title":"Physiol. Behav."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/10253890500456287","article-title":"Enhanced involvement of brain vasopressin V1 receptors in cardiovascular responses to stress in rats with myocardial infarction","volume":"8","author":"Dobruch","year":"2005","journal-title":"Stress"},{"key":"ref_46","first-page":"11","article-title":"Vasopressin, Central Autonomic Control and Blood Pressure Regulation","volume":"26","author":"Murphy","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Szczepanska-Sadowska, E., Wsol, A., Cudnoch-Jedrzejewska, A., Czarzasta, K., and \u017bera, T. (2022). Multiple aspects of inappropriate action of renin-angiotensin, vasopressin, and oxytocin systems in neuropsychiatric and neurodegenerative diseases. J. Clin. Med., 11.","DOI":"10.3390\/jcm11040908"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCULATIONAHA.111.021352","article-title":"Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through G\u03b1q-mediated cell signaling","volume":"124","author":"Li","year":"2011","journal-title":"Circulation"},{"key":"ref_49","first-page":"R1217","article-title":"Prolonged stimulation of intrarenal V1 vasopressin receptors results in sustained hypertension","volume":"267","author":"Stepniakowski","year":"1994","journal-title":"Am. J. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/10253890802687688","article-title":"Central oxytocin modulation of acute stress-induced cardiovascular responses after myocardial infarction in the rat","volume":"12","author":"Kowalewski","year":"2009","journal-title":"Stress"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/10253890.2013.872620","article-title":"Oxytocin differently regulates pressor responses to stress in WKY and SHR rats: The role of central oxytocin and V1a receptors","volume":"17","author":"Wsol","year":"2014","journal-title":"Stress"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"R160","DOI":"10.1152\/ajpregu.00050.2019","article-title":"Impaired hypotensive effects of centrally acting oxytocin in SHR and WKY rats exposed to chronic mild stress","volume":"318","author":"Wsol","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00000658-198004000-00017","article-title":"Mechanisms of impaired cardiac function by vasopressin","volume":"191","author":"Wilson","year":"1980","journal-title":"Ann. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.resuscitation.2006.07.030","article-title":"Arginine vasopressin during sinus rhythm: Effects on haemodynamic variables, left anterior descending coronary artery cross sectional area and cardiac index, before and after inhibition of NO-synthase, in pigs","volume":"74","author":"Mayr","year":"2007","journal-title":"Resuscitation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.resuscitation.2004.07.013","article-title":"Effects of intravenous arginine vasopressin on epicardial coronary artery cross sectional area in a swine resuscitation model","volume":"64","author":"Wenzel","year":"2005","journal-title":"Resuscitation"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0022-2828(03)00053-1","article-title":"The role of arginine vasopressin and its receptors in the normal and failing rat heart","volume":"35","author":"Chandrashekhar","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1677\/joe.0.0990077","article-title":"Release of vasopressin in response to hypoxia and the effect of aminergic and opioid antagonists","volume":"99","author":"Forsling","year":"1983","journal-title":"J. Endocrinol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"744177","DOI":"10.3389\/fphys.2021.744177","article-title":"Vasopressin and breathing: Review of evidence for respiratory effects of the antidiuretic hormone","volume":"12","author":"Proczka","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_59","first-page":"R127","article-title":"Antidiuresis and vasopressin release with hypoxemia and hypercapnia in conscious dogs","volume":"247","author":"Rose","year":"1984","journal-title":"Am. J. Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1172\/JCI111427","article-title":"Role of arginine vasopressin and angiotensin II in cardiovascular responses to combined acute hypoxemia and hypercapnic acidosis in conscious dogs","volume":"74","author":"Rose","year":"1984","journal-title":"J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000123933","article-title":"Effects of hypoxia on vasopressin concentrations in cerebrospinal fluid and plasma of sheep","volume":"38","author":"Stark","year":"1984","journal-title":"Neuroendocrinology"},{"key":"ref_62","first-page":"E449","article-title":"Vasopressin in plasma and cerebrospinal fluid of dogs during hypoxia or acidosis","volume":"247","author":"Wang","year":"1984","journal-title":"Am. J. Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.resp.2010.08.001","article-title":"Modulation of cardiorespiratory function mediated by the paraventricular nucleus","volume":"174","author":"Kc","year":"2010","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2018.12.011","article-title":"Activation of the hypothalamic paraventricular nucleus by acute intermittent hypoxia: Implications for sympathetic long-term facilitation neuroplasticity","volume":"314","author":"Maruyama","year":"2019","journal-title":"Exp. Neurol."},{"key":"ref_65","first-page":"1035","article-title":"Effects of angiotensin II on release of CRH and AVP from hypothalamus during acute hypoxia","volume":"21","author":"Wu","year":"2000","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_66","first-page":"H1316","article-title":"Role of vasopressin in the cardiovascular response to hypoxia in the conscious rat","volume":"251","author":"Walker","year":"1986","journal-title":"Am. J. Physiol."},{"key":"ref_67","first-page":"H743","article-title":"Role of nitric oxide in vasopressinergic pulmonary vasodilatation","volume":"262","author":"Russ","year":"1992","journal-title":"Am. J. Physiol."},{"key":"ref_68","first-page":"H415","article-title":"Vasopressin-induced pulmonary vasodilation in rats","volume":"257","author":"Walker","year":"1989","journal-title":"Am. J. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1113\/jphysiol.2009.184580","article-title":"Increased vasopressin transmission from the paraventricular nucleus to the rostral medulla augments cardiorespiratory outflow in chronic intermittent hypoxia-conditioned rats","volume":"588","author":"Kc","year":"2010","journal-title":"J. Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1152\/japplphysiol.01414.2005","article-title":"Arginine-vasopressin mediates central and peripheral glucose regulation in response to carotid body receptor stimulation with Na-cyanide","volume":"100","author":"Montero","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/jappl.1989.66.1.151","article-title":"Hemodynamic effects of arginine vasopressin in rats adapted to chronic hypoxia","volume":"66","author":"Jin","year":"1989","journal-title":"J. Appl. Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autneu.2006.02.008","article-title":"Cardiac nociceptors innervated by vagal afferents in rats","volume":"126\u2013127","author":"Hisata","year":"2006","journal-title":"Auton. Neurosci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.cjca.2011.09.010","article-title":"From heart to brain: The genesis and processing of cardiac pain","volume":"28","author":"Rosen","year":"2012","journal-title":"Can. J. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2265.1978.tb02156.x","article-title":"The effect of pain on plasma arginine vasopressin concentrations in man","volume":"8","author":"Kendler","year":"1978","journal-title":"Clin. Endocrinol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"102046","DOI":"10.1016\/j.npep.2020.102046","article-title":"Differential role of specific cardiovascular neuropeptides in pain regulation: Relevance to cardiovascular diseases","volume":"81","author":"Sadowski","year":"2020","journal-title":"Neuropeptides"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.npep.2006.12.005","article-title":"Arginine vasopressin is an important regulator in antinociceptive modulation of hypothalamic paraventricular nucleus in the rat","volume":"41","author":"Yang","year":"2007","journal-title":"Neuropeptides"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.regpep.2007.01.006","article-title":"Arginine vasopressin induces periaqueductal gray release of enkephalin and endorphin relating to pain modulation in the rat","volume":"142","author":"Yang","year":"2007","journal-title":"Regul. Pept."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.peptides.2009.03.014","article-title":"Arginine vasopressin antinociception in the rat nucleus raphe magnus is involved in the endogenous opiate peptide and serotonin system","volume":"30","author":"Yang","year":"2009","journal-title":"Peptides"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.peptides.2009.05.026","article-title":"Arginine vasopressin in hypothalamic paraventricular nucleus is transferred to the nucleus raphe magnus to participate in pain modulation","volume":"30","author":"Yang","year":"2009","journal-title":"Peptides"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.biopsych.2015.07.019","article-title":"Vasopressin boosts placebo analgesic effects in women: A randomized trial","volume":"79","author":"Colloca","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.pain.2013.05.003","article-title":"Neurohormonal effects of oxytocin and vasopressin receptor agonists on spinal pain processing in male rats","volume":"154","author":"Juif","year":"2013","journal-title":"Pain"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0196-9781(84)90017-2","article-title":"Vasopressin analgesia: Specificity of action and non-opioid effects","volume":"5","author":"Kordower","year":"1984","journal-title":"Peptides"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.peptides.2012.07.029","article-title":"Effect of intranasal arginine vasopressin on human headache","volume":"38","author":"Yang","year":"2012","journal-title":"Peptides"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.npep.2015.06.002","article-title":"The role of arginine vasopressin in electroacupuncture treatment of primary sciatica in human","volume":"52","author":"Zhao","year":"2015","journal-title":"Neuropeptides"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0361-9230(01)00493-2","article-title":"Microinjection of arginine vasopressin into the central nucleus of amygdala suppressed nociceptive jaw opening reflex in freely moving rats","volume":"55","author":"Ahn","year":"2001","journal-title":"Brain Res. Bull."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/00207458508985394","article-title":"Differential effects of dPTyr(Me)AVP, a vasopressin antagonist, upon foot shock analgesia","volume":"28","author":"Kordower","year":"1985","journal-title":"Int. J. Neurosci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2015.03.023","article-title":"Spinal vasopressin alleviates formalin-induced nociception by enhancing GABAA receptor function in mice","volume":"593","author":"Peng","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1111\/bph.12635","article-title":"Oxytocin inhibits the activity of acid-sensing ion channels through the vasopressin, V1A receptor in primary sensory neurons","volume":"171","author":"Qiu","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3389\/fnins.2017.00567","article-title":"Social context, stress, neuropsychiatric disorders, and the vasopressin 1b receptor","volume":"11","author":"Caldwell","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1530\/EJE-14-0405","article-title":"Copeptin concentrations during psychological stress: The PsyCo study","volume":"171","author":"Siegenthaler","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/cphy.c150053","article-title":"Magnocellular neurons and posterior pituitary function","volume":"6","author":"Brown","year":"2016","journal-title":"Compr. Physiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e12856","DOI":"10.1111\/jne.12856","article-title":"Somato-dendritic vasopressin and oxytocin secretion in endocrine and autonomic regulation","volume":"32","author":"Brown","year":"2020","journal-title":"J. Neuroendocrinol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e12808","DOI":"10.1111\/jne.12808","article-title":"Acute myocardial infarction activates magnocellular vasopressin and oxytocin neurones","volume":"31","author":"Roy","year":"2019","journal-title":"J. Neuroendocrinol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"20812","DOI":"10.1038\/srep20812","article-title":"Analyzing the release of copeptin from the heart in acute myocardial infarction using a transcoronary gradient model","volume":"6","author":"Boeckel","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2265.1994.tb02489.x","article-title":"Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction","volume":"40","author":"Donald","year":"1994","journal-title":"Clin. Endocrinol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0002-9343(88)90206-9","article-title":"Neuroendocrine changes in acute myocardial infarction","volume":"84","author":"McAlpine","year":"1988","journal-title":"Am. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11883-014-0421-5","article-title":"Copeptin-marker of acute myocardial infarction","volume":"16","author":"Searle","year":"2014","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1002\/ehf2.13439","article-title":"Copeptin as a predictive marker of incident heart failure","volume":"8","author":"Schill","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/j.peptides.2011.10.023","article-title":"The cardioprotective effect of different doses of vasopressin (AVP) against ischemia-reperfusion injuries in the anesthetized rat heart","volume":"32","author":"Nazari","year":"2011","journal-title":"Peptides"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.resuscitation.2010.10.004","article-title":"Does prearrest adrenergic integrity affect pressor response? A comparison of epinephrine and vasopressin in a spontaneous ventricular fibrillation swine model","volume":"82","author":"Youngquist","year":"2011","journal-title":"Resuscitation"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0022-5223(19)34788-9","article-title":"Altered effects of vasopressin on the coronary circulation after ischemia","volume":"104","author":"Sellke","year":"1992","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.jtcvs.2018.05.090","article-title":"Enhanced coronary arteriolar contraction to vasopressin in patients with diabetes after cardiac surgery","volume":"156","author":"Sellke","year":"2018","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0300-9572(97)00060-9","article-title":"Synergistic effects of vasopressin plus epinephrine during cardiopulmonary resuscitation","volume":"35","author":"Mulligan","year":"1997","journal-title":"Resuscitation"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1213\/01.ANE.0000066017.66951.7F","article-title":"Survival with full neurologic recovery after prolonged cardiopulmonary resuscitation with a combination of vasopressin and epinephrine in pigs","volume":"96","author":"Stadlbauer","year":"2003","journal-title":"Anesth. Analg."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1213\/00000539-200009000-00024","article-title":"Vasopressin improves survival after cardiac arrest in hypovolemic shock","volume":"91","author":"Voelckel","year":"2000","journal-title":"Anesth. Analg."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0300-9572(02)00096-5","article-title":"Combination drug therapy with vasopressin, adrenaline (epinephrine) and nitroglycerin improves vital organ blood flow in a porcine model of ventricular fibrillation","volume":"54","author":"Lurie","year":"2002","journal-title":"Resuscitation"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.resuscitation.2008.01.025","article-title":"Anti-arrhythmic and vasopressor medications for the treatment of ventricular fibrillation in severe hypothermia: A systematic review of the literature","volume":"78","author":"Wira","year":"2008","journal-title":"Resuscitation"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/hrt.75.2.145","article-title":"Release of endogenous vasopressors during and after cardiopulmonary resuscitation","volume":"75","author":"Lindner","year":"1996","journal-title":"Heart"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00000542-199210000-00008","article-title":"Stress hormone response during and after cardiopulmonary resuscitation","volume":"77","author":"Lindner","year":"1992","journal-title":"Anesthesiology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00075198-200106000-00004","article-title":"Arginine vasopressin during cardiopulmonary resuscitation and vasodilatory shock: Current experience and future perspectives","volume":"7","author":"Krismer","year":"2001","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)80087-6","article-title":"Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation","volume":"349","author":"Lindner","year":"1997","journal-title":"Lancet"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.7326\/0003-4819-124-12-199606150-00006","article-title":"Vasopressin administration in refractory cardiac arrest","volume":"124","author":"Lindner","year":"1996","journal-title":"Ann. Inter. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MCC.0b013e328263885e","article-title":"Vasopressin in vasodilatory and septic shock","volume":"13","author":"Russell","year":"2007","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_114","first-page":"822","article-title":"Torsade de pointes complicating the treatment of bleeding esophageal varices: Association with neuroleptics, vasopressin, and electrolyte imbalance","volume":"90","author":"Faigel","year":"1995","journal-title":"Am. J. Gastroenterol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/00365520801905304","article-title":"Terlipressin-induced ventricular arrhythmia","volume":"43","author":"Urge","year":"2008","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jcrc.2014.03.005","article-title":"Early vasopressin reduces incidence of new onset arrhythmias","volume":"29","author":"Reardon","year":"2014","journal-title":"J. Crit. Care"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(01)05328-4","article-title":"Vasopressin versus epinephrine for in hospital cardiac arrest: A randomised controlled trial","volume":"358","author":"Wells","year":"2001","journal-title":"Lancet"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archinte.165.1.17","article-title":"Vasopressin for cardiac arrest: A systematic review and meta-analysis","volume":"165","author":"Aung","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/jn.01103.2006","article-title":"Modulation of a delayed-rectifier K+ current by angiotensin II in rat sympathetic neurons","volume":"98","author":"Acosta","year":"2007","journal-title":"J. Neurophysiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.HYP.0000028001.65341.AA","article-title":"Angiotensin II induces catecholamine release by direct ganglionic excitation","volume":"40","author":"Dendorfer","year":"2002","journal-title":"Hypertension"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/01.RES.0000134762.66794.16","article-title":"Cardiac angiotensin is upregulated in the hearts of unstable angina patients","volume":"94","author":"Luft","year":"2004","journal-title":"Circ. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11906-010-0105-7","article-title":"Angiotensin-converting enzyme 2: Central regulator for cardiovascular function","volume":"12","author":"Xia","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_123","unstructured":"Pilowsky, P.M. (2022). The contribution of angiotensin peptides to cardiovascular regulation in health and disease. Angiotensin: From the Kidney to Coronavirus, Elsevier."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"H2516","DOI":"10.1152\/ajpheart.00424.2007","article-title":"Angiotensin II attenuates myocardial interstitial acetylcholine release in response to vagal stimulation","volume":"293","author":"Kawada","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1113\/jphysiol.2014.275560","article-title":"Knockdown of mineralocorticoid or angiotensin II type 1 receptor gene expression in the paraventricular nucleus prevents angiotensin II hypertension in rats","volume":"592","author":"Chen","year":"2014","journal-title":"J. Physiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"H1242","DOI":"10.1152\/ajpheart.01400.2006","article-title":"Angiotensin II-induced sudden arrhythmic death and electrical remodeling","volume":"293","author":"Fischer","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.hrthm.2008.02.025","article-title":"The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias","volume":"5","author":"Iravanian","year":"2008","journal-title":"Heart Rhythm"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","article-title":"The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases","volume":"125","author":"Li","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI25713","article-title":"Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia\/reperfusion","volume":"116","author":"Mackins","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_130","first-page":"371","article-title":"Hypotensive function of the brain angiotensin-(1-7) in Sprague Dawley and renin transgenic rats","volume":"54","author":"Dobruch","year":"2003","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/01.RES.0000130944.49657.b8","article-title":"Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component","volume":"94","author":"Boddi","year":"2004","journal-title":"Circ. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","article-title":"TGF-beta1 and angiotensin networking in cardiac remodeling","volume":"63","author":"Rosenkranz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/bph.12328","article-title":"Angiotensin II type 1a receptor signalling directly contributes to the increased arrhythmogenicity in cardiac hypertrophy","volume":"170","author":"Yasuno","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuroscience.2018.04.012","article-title":"Angiotensin II type 1a receptors in the subfornical organ modulate neuroinflammation in the hypothalamic paraventricular nucleus in heart failure rats","volume":"381","author":"Yu","year":"2018","journal-title":"Neuroscience"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00000542-196409000-00013","article-title":"Antiarrhythmic and cardiovascular effects of synthetic oxytocin","volume":"25","author":"Katz","year":"1964","journal-title":"Anesthesiology"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00395-009-0076-5","article-title":"Anti-inflammatory effect of oxytocin in rat myocardial infarction","volume":"105","author":"Jankowski","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.3389\/fpsyg.2020.02139","article-title":"The role of oxytocin in cardiovascular protection","volume":"11","author":"Jankowski","year":"2020","journal-title":"Front. Psychol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"11704","DOI":"10.1073\/pnas.94.21.11704","article-title":"Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart","volume":"94","author":"Gutkowska","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"13074","DOI":"10.1073\/pnas.0405324101","article-title":"Oxytocin in cardiac ontogeny","volume":"101","author":"Jankowski","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"14558","DOI":"10.1073\/pnas.95.24.14558","article-title":"Rat heart: A site of oxytocin production and action","volume":"95","author":"Jankowski","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1590\/1414-431x20144095","article-title":"Neuropeptides in the posterodorsal medial amygdala modulate central cardiovascular reflex responses in awake male rats","volume":"48","author":"Quagliotto","year":"2015","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0008-6363(02)00655-7","article-title":"Genistein supplementation stimulates the oxytocin system in the aorta of ovariectomized rats","volume":"57","author":"Wang","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yhbeh.2016.02.004","article-title":"Oxytocin (OT) and arginine-vasopressin (AVP) act on OT receptors and not AVP V1a receptors to enhance social recognition in adult Syrian hamsters (Mesocricetus auratus)","volume":"81","author":"Song","year":"2016","journal-title":"Horm. Behav."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.psyneuen.2014.08.005","article-title":"Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors","volume":"50","author":"Song","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0361-9230(93)90157-7","article-title":"Cardiac, neuroendocrine, and behavioral effects of central amygdaloid vasopressinergic and oxytocinergic mechanisms under stress-free conditions in rats","volume":"32","author":"Roozendaal","year":"1993","journal-title":"Brain Res. Bull."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.peptides.2012.08.001","article-title":"The role of nitric oxide, reactive oxygen species, and protein kinase C in oxytocin-induced cardioprotection in ischemic rat heart","volume":"37","author":"Faghihi","year":"2012","journal-title":"Peptides"},{"key":"ref_147","first-page":"1088","article-title":"Increased oxytocinergic system activity in the cardiac muscle in spontaneously hypertensive SHR rats","volume":"18","author":"Wsol","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-018-9716-x","article-title":"Role of cytokines and inflammation in heart function during health and disease","volume":"23","author":"Bartekova","year":"2018","journal-title":"Heart Fail. Rev."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/jcbfm.2012.88","article-title":"Inflammatory cytokines in experimental and human stroke","volume":"32","author":"Lambertsen","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Maida, C.D., Norrito, R.L., Daidone, M., Tuttolomondo, A., and Pinto, A. (2020). Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186454"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"828447","DOI":"10.3389\/fimmu.2022.828447","article-title":"Interleukins and Ischemic Stroke","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Baci, D., Bosi, A., Parisi, L., Buono, G., Mortara, L., Ambrosio, G., and Bruno, A. (2020). Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197165"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"992653","DOI":"10.3389\/fcvm.2022.992653","article-title":"CD4+ T-lymphocytes exhibit biphasic kinetics post-myocardial infarction","volume":"9","author":"Kumar","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_154","first-page":"1038","article-title":"TNFR1 Contributes to Activation-Induced Cell Death of Pathological CD4+ T Lymphocytes During Ischemic Heart Failure","volume":"7","author":"Kumar","year":"2022","journal-title":"J. Am. Coll. Cardiol. Basic to Trans Science"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Meyer, I.S., Li, X., Meyer, C., Voloshanenko, O., Pohl, S., Boutros, M., Katus, H.A., Frey, N., and Leuschner, F. (2022). Blockade of Wnt Secretion Attenuates Myocardial Ischemia-Reperfusion Injury by Modulating the Inflammatory Response. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012252"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Besse, S., Nadaud, S., Balse, E., and Pavoine, C. (2022). Early protective role of inflammation in cardiac remodeling and heart failure: Focus on TNF\u03b1 and resident macrophages. Cells, 11.","DOI":"10.3390\/cells11071249"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"818890","DOI":"10.3389\/fcvm.2022.818890","article-title":"The role of interleukin-6 family members in cardiovascular diseases","volume":"9","author":"Feng","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10557-020-07071-0","article-title":"Inflammatory cytokines and chemokines as therapeutic targets in heart failure","volume":"34","author":"Hanna","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41392-020-00455-6","article-title":"A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair","volume":"6","author":"Sun","year":"2021","journal-title":"Signal. Transduct. Target Ther."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Szabo, T.M., Frigy, A., and Nagy, E.E. (2021). Targeting mediators of inflammation in heart failure: A short synthesis of experimental and clinical results. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222313053"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1073\/pnas.92.11.4862","article-title":"Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice","volume":"92","author":"Hirota","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2006.04.122","article-title":"Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II","volume":"1100","author":"Ufnal","year":"2006","journal-title":"Brain Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cyto.2006.01.003","article-title":"Inhibition of brain nitric oxide synthesis enhances and prolongs the hypertensive effect of centrally administered interleukin-1beta in rats","volume":"33","author":"Ufnal","year":"2006","journal-title":"Cytokine"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Ufnal, M., Zera, T., and Szczepa\u0144ska-Sadowska, E. Blockade of angiotensin II AT1 receptors inhibits pressor action of centrally administered interleukin-1beta in Sprague Dawley rats. Neuropeptides, 39, 581\u2013585.","DOI":"10.1016\/j.npep.2005.08.001"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cyto.2014.10.019","article-title":"TNF and angiotensin type 1 receptors interact in the brain control of blood pressure in heart failure","volume":"71","author":"Ufnal","year":"2015","journal-title":"Cytokine"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1538\/expanim.21-0064","article-title":"Suppression of ADAM8 attenuates angiotensin II-induced cardiac fibrosis and endothelial-mesenchymal transition via inhibiting TGF-\u03b21\/Smad2\/Smad3 pathways","volume":"71","author":"Yao","year":"2022","journal-title":"Exp. Anim."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1749-6632.1993.tb55558.x","article-title":"Central effects of interleukin-1 on blood pressure, thermogenesis, and the release of vasopressin, ACTH, and atrial natriuretic peptide","volume":"689","author":"Kimura","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/ajh\/5.4.224","article-title":"Effects of interleukin-1 beta on blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats","volume":"5","author":"Takahashi","year":"1992","journal-title":"Am. J. Hypertens."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/mol.116.107698","article-title":"GRK2 mediates arginine vasopressin-induced interleukin-6 production via nuclear factor-\u03baB signaling neonatal rat cardiac fibroblast","volume":"92","author":"Xu","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/FJC.0b013e3181d706ae","article-title":"Effects of arginine vasopressin on differentiation of cardiac fibroblasts into myofibroblasts","volume":"55","author":"Hui","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.1631560","article-title":"Negative inotropic effects of cytokines on the heart mediated by nitric oxide","volume":"257","author":"Finkel","year":"1992","journal-title":"Science"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/01.HYP.30.5.1112","article-title":"Arginine vasopressin increases nitric oxide synthesis in cytokine-stimulated rat cardiac myocytes","volume":"30","author":"Yamamoto","year":"1997","journal-title":"Hypertension"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0304-4165(75)90294-9","article-title":"Metabolic actions of vasopressin, glucagon and adrenalin in the intact rat","volume":"411","author":"Hems","year":"1975","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_174","first-page":"E1095","article-title":"Effect of AVP and oxytocin on insulin release: Involvement of V1b receptors","volume":"269","author":"Lee","year":"1995","journal-title":"Am. J. Physiol."},{"key":"ref_175","first-page":"829","article-title":"Aldosterone and mineralocorticoid receptors in regulation of the cardiovascular system and pathological remodelling of the heart and arteries","volume":"69","author":"Sztechman","year":"2018","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"E127","DOI":"10.1152\/ajpendo.00269.2016","article-title":"Acute and chronic hyperglycemic effects of vasopressin in normal rats: Involvement of V1A receptors","volume":"312","author":"Taveau","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0024-3205(98)00463-9","article-title":"Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: Involvement of V1b receptors","volume":"63","author":"Hsu","year":"1998","journal-title":"Life Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/22\/14414\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:22:11Z","timestamp":1760145731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/22\/14414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,20]]},"references-count":177,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijms232214414"],"URL":"https:\/\/doi.org\/10.3390\/ijms232214414","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,20]]}}}